Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 4 patents
76 readers on Mendeley
1 readers on CiteULike
  • Article usage
  • Citations to this article (662)

Advertisement

Research Article Free access | 10.1172/JCI105568

In Vitro Bactericidal Capacity of Human Polymorphonuclear Leukocytes: Diminished Activity in Chronic Granulomatous Disease of Childhood

P. G. Quie, J. G. White, B. Holmes, and R. A. Good

Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn.

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minn.

†

John and Mary R. Markle Scholar in Academic Medicine. Recipient of U. S. Public Health Service Career Development Award (5-K3-AI-10, 109-05).

Address requests for reprints to Dr. P. G. Quie, Dept. of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn. 55455.

‡

American Legion Memorial Heart Research Professor of Pediatrics and Microbiology.

*

Submitted for publication October 31, 1966; accepted December 30, 1966.

Supported in part by National Foundation, American Heart Association, and U. S. Public Health Service (AI-06931, HE-02085, AI-00798, and NB-02042) grants and the Commission on Streptococcal and Staphylococcal Diseases, Armed Forces Epidemiological Board, Office of the Surgeon General, Dept. of the Army, Washington, D. C.

Presented in part at the 58th Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N. J., May 2, 1966.

Find articles by Quie, P. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn.

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minn.

†

John and Mary R. Markle Scholar in Academic Medicine. Recipient of U. S. Public Health Service Career Development Award (5-K3-AI-10, 109-05).

Address requests for reprints to Dr. P. G. Quie, Dept. of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn. 55455.

‡

American Legion Memorial Heart Research Professor of Pediatrics and Microbiology.

*

Submitted for publication October 31, 1966; accepted December 30, 1966.

Supported in part by National Foundation, American Heart Association, and U. S. Public Health Service (AI-06931, HE-02085, AI-00798, and NB-02042) grants and the Commission on Streptococcal and Staphylococcal Diseases, Armed Forces Epidemiological Board, Office of the Surgeon General, Dept. of the Army, Washington, D. C.

Presented in part at the 58th Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N. J., May 2, 1966.

Find articles by White, J. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn.

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minn.

†

John and Mary R. Markle Scholar in Academic Medicine. Recipient of U. S. Public Health Service Career Development Award (5-K3-AI-10, 109-05).

Address requests for reprints to Dr. P. G. Quie, Dept. of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn. 55455.

‡

American Legion Memorial Heart Research Professor of Pediatrics and Microbiology.

*

Submitted for publication October 31, 1966; accepted December 30, 1966.

Supported in part by National Foundation, American Heart Association, and U. S. Public Health Service (AI-06931, HE-02085, AI-00798, and NB-02042) grants and the Commission on Streptococcal and Staphylococcal Diseases, Armed Forces Epidemiological Board, Office of the Surgeon General, Dept. of the Army, Washington, D. C.

Presented in part at the 58th Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N. J., May 2, 1966.

Find articles by Holmes, B. in: JCI | PubMed | Google Scholar

Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn.

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minn.

†

John and Mary R. Markle Scholar in Academic Medicine. Recipient of U. S. Public Health Service Career Development Award (5-K3-AI-10, 109-05).

Address requests for reprints to Dr. P. G. Quie, Dept. of Pediatrics, University of Minnesota Medical School, Minneapolis, Minn. 55455.

‡

American Legion Memorial Heart Research Professor of Pediatrics and Microbiology.

*

Submitted for publication October 31, 1966; accepted December 30, 1966.

Supported in part by National Foundation, American Heart Association, and U. S. Public Health Service (AI-06931, HE-02085, AI-00798, and NB-02042) grants and the Commission on Streptococcal and Staphylococcal Diseases, Armed Forces Epidemiological Board, Office of the Surgeon General, Dept. of the Army, Washington, D. C.

Presented in part at the 58th Annual Meeting of the American Society for Clinical Investigation, Atlantic City, N. J., May 2, 1966.

Find articles by Good, R. in: JCI | PubMed | Google Scholar

Published April 1, 1967 - More info

Published in Volume 46, Issue 4 on April 1, 1967
J Clin Invest. 1967;46(4):668–679. https://doi.org/10.1172/JCI105568.
© 1967 The American Society for Clinical Investigation
Published April 1, 1967 - Version history
View PDF
Abstract

Diminished bactericidal capacity was found to be characteristic of polymorphonuclear leukocytes (PMN) from five children with the clinical syndrome of granulomatous disease of childhood. The PMN from these children demonstrated nearly normal phagocytic capacity, and the majority of viable bacteria, after 2 hours of incubation in the phagocytosis system, were found associated with leukocytes.

The morphology of the unstimulated polymorphonuclear leukocytes from patients with chronic granulomatous disease was similar to those from normal persons of similar ages by light and electron microscopy. In addition, the total lysozyme and phagocytin activity of leukocyte extracts from these patients was similar to those from equal numbers of leukocytes from controls.

A striking difference in the cytoplasmic response after phagocytosis characterized the PMN of the patients with granulomatous disease. Whereas degranulation, vacuole formation, and rapid bacterial digestion were the rule in the PMN from controls, little degranulation and persistence of intact bacteria in the cytoplasm characterized disease.

The deficiency of bactericidal capacity and the minimal degranulation after active phagocytosis by the PMN of these children with an inherited syndrome suggest that separate metabolic processes are involved in phagocytosis and in intracellular digestion. Continuing study of the metabolic function of leukocytes from these children should provide an opportunity for increased understanding of the metabolic basis for degranulation and intracellular digestion in phagocytic cells.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 668
page 668
icon of scanned page 669
page 669
icon of scanned page 670
page 670
icon of scanned page 671
page 671
icon of scanned page 672
page 672
icon of scanned page 673
page 673
icon of scanned page 674
page 674
icon of scanned page 675
page 675
icon of scanned page 676
page 676
icon of scanned page 677
page 677
icon of scanned page 678
page 678
icon of scanned page 679
page 679
Version history
  • Version 1 (April 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (662)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 patents
76 readers on Mendeley
1 readers on CiteULike
See more details